Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Mariani, Francesco ^a   Sena, Paola ^a   Pedroni, Monica ^a   Benatti, Piero ^a   Manni, Paola ^a   Di Gregorio, Carmela ^a   Manenti, Antonio ^a   Palumbo, Carla ^a   de Leon, Maurizio Ponz ^a   Roncucci, Luca ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; TH INDUCING POZ KRUPPEL FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ABERRANT CRYPT FOCUS; ARTICLE; CD4+ T LYMPHOCYTE; CD56+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MICROADENOMA; PROTEIN FUNCTION; PROTEIN LOCALIZATION; T LYMPHOCYTE; TUMOR IMMUNITY;

ABERRANT CRYPT FOCI; ADENOMA; CARCINOMA; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MUCOUS MEMBRANE; TRANSCRIPTION FACTORS;

EID: 84872577544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054488     Document Type: Article

References (51)

1. Dunn GP, Old LJ, Schreiber RD, (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 21(2): 137-48.
2. Knaapen AM, Güngör N, Schins RP, Borm PJ, Van Schooten FJ, (2006) Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis. 21(4): 225-36.
3. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature. 420(6917): 860-7.
4. Watt AG, House AK, (1978) Colonic carcinoma: a quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis. Cancer. 41(1): 279-82.
5. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, et al. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 313(5795): 1960-4.
6. Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, et al. (2009) In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol. 27(35): 5944-51.
7. Mlecnik B, Tosolini M, Charoentong P, Kirilovsky A, Bindea G, et al. (2010) Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology. 138(4): 1429-40.
8. Parmiani G, (2005) Tumor-infiltrating T cells-friend or foe of neoplastic cells? N Engl J Med. 353(25): 2640-1.
9. Disis ML, Bernhard H, Jaffee EM (2009) Use of tumour-responsive T cells as cancer treatment. Lancet. 373(9664): 673-83. Review.
10. Mulder WM, Bloemena E, Stukart MJ, Kummer JA, Wagstaff J, et al. (1997) T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut. 40(1): 113-9.
11. Lowin B, Hahne M, Mattmann C, Tschopp J (1994) Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature. 370(6491):6 50-2.
12. Barry M, Bleackley RC, (2002) Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol. 2(6): 401-9.
13. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, et al. (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 353(25): 2654-66.
14. Diederichsen AC, Hjelmborg JB, Christensen PB, Zeuthen J, Fenger C, (2003) Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother. 52(7): 423-8.
15. McLean MH, Murray GI, Stewart KN, Norrie G, Mayer C, et al. (2011) The inflammatory microenvironment in colorectal neoplasia. PLoS One. 6(1): e15366.
16. Betts G, Jones E, Junaid S, El-Shanawany T, Scurr M, et al. (2011) Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer. Gut. Dec 29.
17. Colonna M, (2009) Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity. 31(1): 15-23.
18. Vivier E, Spits H, Cupedo T, (2009) Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat Rev Immunol. 9(4): 229-34.
19. Finn OJ, (2008) Cancer immunology. N Engl J Med. 358(25): 2704-15.
20. Guven H, Gilljam M, Chambers BJ, Ljunggren HG, Christensson B, et al. (2003) Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy. Leukemia. 17(10): 1973-80.
21. Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, et al. (1997) The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer. 79(12): 2320-8.
22. Halama N, Braun M, Kahlert C, Spille A, Quack C, et al. (2011) Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res. 17(4): 678-89.
23. Gulubova M, Manolova I, Kyurkchiev D, Julianov A, Altunkova I, (2009) Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases. APMIS. 117(12): 870-9.
24. O'Keeffe J, Doherty DG, Kenna T, Sheahan K, O'Donoghue DP, et al. (2004) Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer. Eur J Immunol. 34(8): 2110-9.
25. He X, He X, Dave VP, Zhang Y, Hua X, et al. (2005) The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature. 433(7028): 826-33.
26. Sun G, Liu X, Mercado P, Jenkinson SR, Kypriotou M, et al. (2005) The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat Immunol. 6(4): 373-81.
27. Keefe R, Dave V, Allman D, Wiest D, Kappes DJ, (1999) Regulation of lineage commitment distinct from positive selection. Science. 286(5442): 1149-53.
28. Jenkinson SR, Intlekofer AM, Sun G, Feigenbaum L, Reiner SL, et al. (2007) Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation. J Exp Med. 204(2): 267-72.
29. Wang L, Wildt KF, Castro E, Xiong Y, Feigenbaum L, et al. (2008) The zinc finger transcription factor Zbtb7b represses CD8-lineage gene expression in peripheral CD4+ T cells. Immunity. 29(6): 876-87.
30. Di Gregorio C, Losi L, Fante R, Modica S, Ghidoni M, et al. (1997) Histology of aberrant crypt foci in the human colon. Histopathology 30: 328-34.
31. Mariani F, Sena P, Marzona L, Riccio M, Fano R, et al. (2009) Cyclooxygenase-2 and Hypoxia-Inducible Factor-1α protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Letters 279: 221-29.
32. Sena P, Roncucci L, Marzona L, Mariani F, Maffei S, et al. (2010) Altered expression of apoptosis biomarkers in human colorectal microadenomas. Cancer Epidemiol Biomarkers Prev. 19(2): 351-7.
33. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25(4): 402-8.
34. Bolte S, Cordelières FP, (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 224(Pt 3): 213-32.
35. Fletcher PA, Scriven DR, Schulson MN, Moore ED, (2010) Multi-image colocalization and its statistical significance. Biophys J. 22 99(6): 1996-2005.
36. Roncucci L, Medline A, Bruce WR, (1991) Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev. 1(1): 57-60.
37. Bindea G, Mlecnik B, Fridman WH, Galon J, (2011) The prognostic impact of anti-cancer immune response: a novel classification of cancer patients. Semin Immunopathol. 33(4): 335-40.
38. Guidoboni M, Gafà R, Viel A, Doglioni C, Russo A, et al. (2001) Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol. 159(1): 297-304.
39. Frey AB, Monu N, (2006) Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response. J Leukoc Biol. 79(4): 652-62.
40. Koch M, Beckhove P, Op den Winkel J, Autenrieth D, Wagner P, et al. (2006) Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Ann Surg. 244(6): 986-92; discussion 992-3.
41. Mulder WM, Bloemena E, Stukart MJ, Kummer JA, Wagstaff J, et al. (1997) T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut. 40(1): 113-9.
42. Radoja S, Frey AB (2000) Cancer-induced defective cytotoxic T lymphocyte effector function: another mechanism how antigenic tumors escape immune-mediated killing. Mol Med. 6(6): 465-79. Review.
43. Koneru M, Schaer D, Monu N, Ayala A, Frey AB, (2005) Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function. J Immunol. 174(4): 1830-40.
44. Monu N, Frey AB, (2007) Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells. Cancer Res. 67(23): 11447-54.
45. Setoguchi R, Taniuchi I, Bevan MJ, (2009) ThPOK derepression is required for robust CD8 T cell responses to viral infection. J Immunol. 183(7): 4467-74.
46. Lin YC, Mahalingam J, Chiang JM, Su PJ, Chu YY, et al. (2012) Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer. Int J Cancer. doi: 10.1002/ijc.27784.
47. Ma C, Dong X, (2011) Colorectal cancer-derived Foxp3(+) IL-17(+) T cells suppress tumour-specific CD8+ T cells. Scand J Immunol. 74(1): 47-51.
48. Soong R, Shah N, Peh BK, Chong PY, Ng SS, et al. (2009) The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome. Br J Cancer. 10 100(5): 676-9.
49. Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, et al. (2011) Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 29(6): 610-8.
50. Walzer T, Jaeger S, Chaix J, Vivier E, (2007) Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol. 19(3): 365-72.
51. Wang L, Carr T, Xiong Y, Wildt KF, Zhu J, et al. (2010) The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells. Eur J Immunol. 40(9): 2385-90.